In an exploratory serum proteomic analysis of patients with central serous chorioretinopathy (CSCR), levels of CLEC3B have been reported to potentially exhibit a decreasing trend, but this finding has not been adequately validated in independent, peer-reviewed cohort studies [ 123 ].
← all excerpts
Unveiling the Mysteries of CLEC3B: Physiological Roles, Pathological Impacts, and Research Gaps.
1
—
—